$MXCT news
The latest MXCT stock news: headlines, filings, AI summaries and sentiment for $MXCT, updated around the clock.
- MaxCyte to Acquire Akron Bio to Drive Revenue Growth and Profitability
- MaxCyte Reports Q3 2026 Revenue Growth and Raised Full-Year Guidance Following Akron Bio Acquisition
- MAXCYTE, INC. - 10-Q Filing
- MaxCyte Shares Decline Following $151.8 Million Acquisition of Akron Bio
- MAXCYTE, INC. - 8-K Filing
- MAXCYTE, INC. - 8-K Filing
- MaxCyte Reports Q2 2026 Earnings with Revenue Decline but Reduced Net Loss
- MAXCYTE, INC. - 8-K Filing